Stock Events

Acadia Pharmaceuticals (ACAD) Q3 2017 Earnings

ACAD +0.17%
8AugConfirmed
Q4 2016
Q1 2017
Q2 2017
Q3 2017
-0.73
-0.67
-0.61
-0.55

Details

Expected EPS
-0.72
Actual EPS
-0.55
Surprise EPS
0.17
Surprise Percent
+23.61%

Description

Acadia Pharmaceuticals (ACAD) has reported earnings of -0.55 per share for Q3 2017.

0 Comments

Share your thoughts